Long COVID patients seek more federal research on treatments.

Long COVID patients push to see federal research refocused on treatments The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs. NPR

...

Despite long COVID's vast reach, the federal government's investment in researching the disease — to the tune of $1.15 billion to date — has so far failed to bring any new treatments to market. This disappoints and angers the patient community.

"It's unconscionable that more than four years since this began, we still don't have one FDA- approved drug," says Meighan Stone, executive director of Long COVID Campaign, a patient-led advocacy organization. Stone was among several people with long COVID who spoke at a workshop hosted by the National Institutions of Health in September where patients, clinicians and researchers discussed their priorities and frustrations around the agency's approach to long COVID research.

...